Cargando…
Accelerated Development of COVID-19 Vaccines: Technology Platforms, Benefits, and Associated Risks
Multiple preventive COVID-19 vaccines have been developed during the ongoing SARS coronavirus (CoV) 2 pandemic, utilizing a variety of technology platforms, which have different properties, advantages, and disadvantages. The acceleration in vaccine development required to combat the current pandemic...
Autores principales: | Wagner, Ralf, Hildt, Eberhard, Grabski, Elena, Sun, Yuansheng, Meyer, Heidi, Lommel, Annette, Keller-Stanislawski, Brigitte, Müller-Berghaus, Jan, Cichutek, Klaus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310218/ https://www.ncbi.nlm.nih.gov/pubmed/34358163 http://dx.doi.org/10.3390/vaccines9070747 |
Ejemplares similares
-
Regulatory concepts to guide and promote the accelerated but safe clinical development and licensure of COVID‐19 vaccines in Europe
por: Wagner, Ralf, et al.
Publicado: (2021) -
Chargenprüfung als wesentliche Säule der Versorgung mit sicheren und wirksamen Impfstoffen
por: Sediri-Schön, Hanna, et al.
Publicado: (2022) -
Post‐mortem tissue donation programs as platforms to accelerate cancer research
por: Dankner, Matthew, et al.
Publicado: (2020) -
Accelerating aging with dynamic biomaterials: Recapitulating aged tissue phenotypes in engineered platforms
por: Madl, Christopher M.
Publicado: (2023) -
Hämovigilanz von Blutkomponenten
Meldungen an das Paul-Ehrlich-Institut vom 1.1.1995 bis zum 15.11.1998: Meldungen an das Paul-Ehrlich-Institut vom 1.1.1995 bis zum 15.11.1998
por: Graul, Annette, et al.
Publicado: (1999)